Clinical Study of CD276 Targeted Autologous Chimeric Antigen Receptor T Cell Infusion in Patients With CD276 Positive Advanced Solid Tumor
- Status
- UNKNOWN
- Phase
- EARLY_PHASE1
Clinical Trials Related to Neuroblastoma
Related studies linked through entity extraction aliases.
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
PEACH TRIAL- Precision Medicine and Adoptive Cellular Therapy
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Real World Data Collection Pediatric Neuroblastoma Treated With Lorlatinib
- Status
- TERMINATED
- Phase
- N/A
A Study of Bempegaldesleukin (BEMPEG: NKTR-214) in Combination With Nivolumab in Children, Adolescents and Young Adults With Recurrent or Treatment-resistant Cancer
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Open-Label Study of 18F-mFBG for Imaging Neuroblastoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
18F-DOPA II - PET Imaging Optimization
- Status
- RECRUITING
- Phase
- PHASE3
4SCAR-T Therapy Targeting GD2, PSMA and CD276 for Treating Neuroblastoma
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
68Ga-DOTATATE Neuroblastoma Imaging Pilot
- Status
- RECRUITING
- Phase
- PHASE2
B7H3 CAR T Cell Immunotherapy for Recurrent/Refractory Solid Tumors in Children and Young Adults
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Quality Improvement Project - "My Logbook! - I Know my Way Around!"; ("Mein Logbuch - Ich Kenne Mich Aus!")
- Status
- COMPLETED
- Phase
- NA
Treatment With Dinutuximab, Sargramostim (GM-CSF), and Isotretinoin in Combination With Irinotecan and Temozolomide After Intensive Therapy for People With High-Risk Neuroblastoma (NBL)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Flavored, Oral Irinotecan VAL-413 (Orotecan®) Given With Temozolomide for Treatment of Recurrent Pediatric Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Vorinostat in Combination With Chemotherapy in Relapsed/Refractory Solid Tumors and CNS Malignancies
- Status
- RECRUITING
- Phase
- PHASE1
Eflornithine (DFMO) and Etoposide for Relapsed/Refractory Neuroblastoma
- Status
- RECRUITING
- Phase
- PHASE2
A Post-Authorisation Safety Study Patient Registry of Patients With Neuroblastoma Being Treated With Dinutuximab Beta
- Status
- RECRUITING
- Phase
- N/A
9-ING-41 in Pediatric Patients With Refractory Malignancies.
- Status
- TERMINATED
- Phase
- PHASE1
GVAX Plus Checkpoint Blockade in Neuroblastoma
- Status
- TERMINATED
- Phase
- PHASE1
A Study of LY3295668 Erbumine in Participants With Relapsed/Refractory Neuroblastoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
An Investigational Scan (68Ga-DOTATATE PET/CT) in Diagnosing Pediatric Metastatic Neuroendocrine Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- EARLY_PHASE1